{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:18:40Z","timestamp":1791425920545,"version":"4.3.3"},"reference-count":54,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.vaccine.2006.12.003","type":"journal-article","created":{"date-parts":[[2006,12,14]],"date-time":"2006-12-14T12:10:44Z","timestamp":1166098244000},"page":"2252-2260","source":"Crossref","is-referenced-by-count":27,"title":["Discovery of a vaccine antigen that protects mice from Chlamydia pneumoniae infection"],"prefix":"10.1016","volume":"25","author":[{"given":"Callum","family":"Thorpe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Snelgrove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oretta","family":"Finco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Rae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Grandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratti","family":"Guilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Hussell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2006.12.003_bib1","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/infdis\/167.4.841","article-title":"Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries","volume":"167","author":"Kuo","year":"1993","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2006.12.003_bib2","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1001\/archsurg.134.9.930","article-title":"Does Chlamydia pneumoniae cause atherosclerosis?","volume":"134","author":"Grayston","year":"1999","journal-title":"Arch Surg"},{"issue":"14","key":"10.1016\/j.vaccine.2006.12.003_bib3","doi-asserted-by":"crossref","first-page":"8040","DOI":"10.1073\/pnas.1533181100","article-title":"Chlamydia uncloaked","volume":"100","author":"Byrne","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.vaccine.2006.12.003_bib4","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1128\/IAI.72.4.1843-1855.2004","article-title":"Chlamydial persistence: beyond the biphasic paradigm","volume":"72","author":"Hogan","year":"2004","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2006.12.003_bib5","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1699-0463.1995.tb01436.x","article-title":"The immunobiology and immunopathology of chlamydial infections","volume":"103","author":"Ward","year":"1995","journal-title":"APMIS"},{"key":"10.1016\/j.vaccine.2006.12.003_bib6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S1286-4579(02)01546-0","article-title":"Proteins in the Chlamydial inclusion membrane","volume":"4","author":"Rockey","year":"2002","journal-title":"Microbes Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2006.12.003_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1046\/j.1462-5822.2000.00029.x","article-title":"A secondary structure motif predictive of protein localization to the chlamydial inclusion membrane","volume":"2","author":"Bannantine","year":"2000","journal-title":"Cell Microbiol"},{"issue":"14","key":"10.1016\/j.vaccine.2006.12.003_bib8","doi-asserted-by":"crossref","first-page":"8478","DOI":"10.1073\/pnas.1331135100","article-title":"Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis","volume":"100","author":"Belland","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.vaccine.2006.12.003_bib9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S1357-4310(98)01232-5","article-title":"Vaccines against Chlamydia: approaches and progress","volume":"4","author":"Stagg","year":"1998","journal-title":"Mol Med Today"},{"issue":"1","key":"10.1016\/j.vaccine.2006.12.003_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1586\/14760584.2.1.129","article-title":"Contemporary approaches to designing and evaluating vaccines against Chlamydia","volume":"2","author":"Igietseme","year":"2003","journal-title":"Expert Rev Vaccines"},{"issue":"5","key":"10.1016\/j.vaccine.2006.12.003_bib11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1468-3083.2001.00343.x","article-title":"Chlamydial treatment failures: a persistent problem?","volume":"15","author":"Byrne","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"12","key":"10.1016\/j.vaccine.2006.12.003_bib12","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1128\/AAC.44.12.3288-3297.2000","article-title":"Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro","volume":"44","author":"Dreses-Werringloer","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"9302","key":"10.1016\/j.vaccine.2006.12.003_bib13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0140-6736(02)07463-9","article-title":"Should trachoma be treated with antibiotics?","volume":"359","author":"Dawson","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2006.12.003_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0264-410X(95)80022-6","article-title":"A new computer model for estimating the impact of vaccination protocols and its application to the study of Chlamydia trachomatis genital infections","volume":"13","author":"de la Maza","year":"1995","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2006.12.003_bib15","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/nar\/28.6.1397","article-title":"Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39","volume":"28","author":"Read","year":"2000","journal-title":"Nucleic Acids Res"},{"issue":"5389","key":"10.1016\/j.vaccine.2006.12.003_bib16","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1126\/science.282.5389.754","article-title":"Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis","volume":"282","author":"Stephens","year":"1998","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.vaccine.2006.12.003_bib17","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/7716","article-title":"Comparative genomes of Chlamydia pneumoniae and C. trachomatis","volume":"21","author":"Kalman","year":"1999","journal-title":"Nat Genet"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2006.12.003_bib18","doi-asserted-by":"crossref","first-page":"S521","DOI":"10.1086\/315631","article-title":"Chlamydial genomics and vaccine antigen discovery","volume":"181","author":"Stephens","year":"2000","journal-title":"J Infect Dis"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2006.12.003_bib19","doi-asserted-by":"crossref","first-page":"S528","DOI":"10.1086\/315633","article-title":"Potential relevance of Chlamydia pneumoniae surface proteins to an effective vaccine","volume":"181","author":"Christiansen","year":"2000","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2006.12.003_bib20","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/1522-2683()22:6<1204::AID-ELPS1204>3.0.CO;2-M","article-title":"Proteome analysis of the Chlamydia pneumoniae elementary body","volume":"22","author":"Vandahl","year":"2001","journal-title":"Electrophoresis"},{"issue":"1","key":"10.1016\/j.vaccine.2006.12.003_bib21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S1369-5274(00)00158-2","article-title":"Chlamydia outer membrane protein discovery using genomics","volume":"4","author":"Stephens","year":"2001","journal-title":"Curr Opin Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2006.12.003_bib22","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1128\/IAI.69.4.2383-2389.2001","article-title":"Expression of Chlamydia pneumoniae polymorphic membrane protein family genes","volume":"69","author":"Grimwood","year":"2001","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2006.12.003_bib23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/omi.1.1999.4.187","article-title":"Computational analysis of the polymorphic membrane protein superfamily of Chlamydia trachomatis and Chlamydia pneumoniae","volume":"4","author":"Grimwood","year":"1999","journal-title":"Microb Comp Genomics"},{"issue":"3","key":"10.1016\/j.vaccine.2006.12.003_bib24","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1046\/j.1365-2958.2001.02418.x","article-title":"Heparin-binding outer membrane protein of chlamydiae","volume":"40","author":"Stephens","year":"2001","journal-title":"Mol Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2006.12.003_bib25","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1128\/IAI.67.1.375-383.1999","article-title":"Identification of two novel genes encoding 97- to 99-kilodalton outer membrane proteins of Chlamydia pneumoniae","volume":"67","author":"Knudsen","year":"1999","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2006.12.003_bib26","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1046\/j.1365-2958.2000.02167.x","article-title":"functional analysis of PorB, a Chlamydia porin and neutralizing target","volume":"38","author":"Kubo","year":"2000","journal-title":"Mol Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2006.12.003_bib27","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1128\/IAI.69.5.3082-3091.2001","article-title":"Chlamydia pneumoniae major outer membrane protein is a surface-exposed antigen that elicits antibodies primarily directed against conformation-dependent determinants","volume":"69","author":"Wolf","year":"2001","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2006.12.003_bib28","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1128\/IAI.62.3.880-886.1994","article-title":"Isolation and characterization of a gene encoding a Chlamydia pneumoniae 76-kilodalton protein containing a species-specific epitope","volume":"62","author":"Perez","year":"1994","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2006.12.003_bib29","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1128\/IAI.70.1.368-379.2002","article-title":"Genomic approach for analysis of surface proteins in Chlamydia pneumoniae","volume":"70","author":"Montigiani","year":"2002","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2006.12.003_bib30","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1128\/IAI.71.5.2555-2562.2003","article-title":"Temporal expression of type III secretion genes of Chlamydia pneumoniae","volume":"71","author":"Slepenkin","year":"2003","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2006.12.003_bib31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00430-003-0206-x","article-title":"Expression and localization of type III secretion-related proteins of Chlamydia pneumoniae","volume":"193","author":"Lugert","year":"2004","journal-title":"Med Microbiol Immunol (Berl)"},{"issue":"2","key":"10.1016\/j.vaccine.2006.12.003_bib32","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/0003-2697(91)90534-Z","article-title":"Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase","volume":"192","author":"Guan","year":"1991","journal-title":"Anal Biochem"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2006.12.003_bib33","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0264-410X(00)00237-1","article-title":"Immunity to Chlamydia pneumoniae induced by vaccination with DNA vectors expressing a cytoplasmic protein (Hsp60) or outer membrane proteins (MOMP and Omp2)","volume":"19","author":"Penttila","year":"2000","journal-title":"Vaccine"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2006.12.003_bib34","doi-asserted-by":"crossref","first-page":"S544","DOI":"10.1086\/315605","article-title":"Use of a mouse lung challenge model to identify antigens protective against Chlamydia pneumoniae lung infection","volume":"181","author":"Murdin","year":"2000","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2006.12.003_bib35","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.4049\/jimmunol.162.5.2829","article-title":"Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice","volume":"162","author":"Rottenberg","year":"1999","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2006.12.003_bib36","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.4049\/jimmunol.158.7.3344","article-title":"Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways","volume":"158","author":"Perry","year":"1997","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2006.12.003_bib37","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1128\/IAI.63.12.4661-4668.1995","article-title":"Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection","volume":"63","author":"Morrison","year":"1995","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2006.12.003_bib38","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1128\/IAI.63.2.516-521.1995","article-title":"Role of CD8 T cells in primary Chlamydia infection","volume":"63","author":"Magee","year":"1995","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2006.12.003_bib39","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.4049\/jimmunol.153.11.5183","article-title":"Protective cytotoxic T lymphocytes are induced during murine infection with Chlamydia trachomatis","volume":"153","author":"Starnbach","year":"1994","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2006.12.003_bib40","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1128\/IAI.63.9.3302-3308.1995","article-title":"CD4+ T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract","volume":"63","author":"Su","year":"1995","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2006.12.003_bib41","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.4049\/jimmunol.172.4.2407","article-title":"CD4+ or CD8+ cells are each sufficient for protection against Chlamydia pneumoniae infection through their ability to secrete IFN-gamma","volume":"172","author":"Rothfuchs","year":"2004","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2006.12.003_bib42","doi-asserted-by":"crossref","first-page":"6453","DOI":"10.4049\/jimmunol.167.11.6453","article-title":"IFN-alpha beta-dependent, IFN-gamma secretion by bone marrow-derived macrophages controls an intracellular bacterial infection","volume":"167","author":"Rothfuchs","year":"2001","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2006.12.003_bib43","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1128\/IAI.55.1.223-226.1987","article-title":"Role of natural killer cells in infection with the mouse pneumonitis agent (murine Chlamydia trachomatis)","volume":"55","author":"Williams","year":"1987","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2006.12.003_bib44","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.4049\/jimmunol.164.9.4812","article-title":"Regulation and role of IFN-gamma in the innate resistance to infection with Chlamydia pneumoniae","volume":"164","author":"Rottenberg","year":"2000","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2006.12.003_bib45","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1128\/IAI.66.12.5867-5875.1998","article-title":"Role of NK cells in early host response to chlamydial genital infection","volume":"66","author":"Tseng","year":"1998","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2006.12.003_bib46","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1046\/j.1365-2567.1999.00809.x","article-title":"Depletion of CD8+ cells abolishes memory in acquired immunity against Chlamydia pneumoniae in BALB\/c mice","volume":"97","author":"Penttila","year":"1999","journal-title":"Immunology"},{"issue":"11","key":"10.1016\/j.vaccine.2006.12.003_bib47","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.1128\/IAI.66.11.5457-5461.1998","article-title":"Gamma interferon production by cytotoxic T lymphocytes is required for resolution of Chlamydia trachomatis infection","volume":"66","author":"Lampe","year":"1998","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2006.12.003_bib48","first-page":"284","article-title":"Protection against Chlamydia psittaci in mice conferred by Lyt-2+ T cells","volume":"77","author":"Buzoni-Gatel","year":"1992","journal-title":"Immunology"},{"issue":"9","key":"10.1016\/j.vaccine.2006.12.003_bib49","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.4049\/jimmunol.174.9.5729","article-title":"A CD8+ T cell heptaepitope minigene vaccine induces protective immunity against Chlamydia pneumoniae","volume":"174","author":"Pinchuk","year":"2005","journal-title":"J Immunol"},{"issue":"42","key":"10.1016\/j.vaccine.2006.12.003_bib50","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.1016\/j.vaccine.2005.04.048","article-title":"Chlamydia pneumoniae genome sequence analysis and identification of HLA-A2-restricted CD8+ T cell epitopes recognized by infection-primed T cells","volume":"23","author":"Capo","year":"2005","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2006.12.003_bib51","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1128\/IAI.59.8.2843-2845.1991","article-title":"In vitro neutralization of Chlamydia trachomatis by monovalent Fab antibody specific to the major outer membrane protein","volume":"59","author":"Su","year":"1991","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2006.12.003_bib52","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1128\/IAI.56.5.1320-1325.1988","article-title":"Resolution of chlamydial genital infection in B-cell-deficient mice and immunity to reinfection","volume":"56","author":"Ramsey","year":"1988","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2006.12.003_bib53","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1128\/IAI.65.6.1993-1999.1997","article-title":"Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice","volume":"65","author":"Su","year":"1997","journal-title":"Infect Immun"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2006.12.003_bib54","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.vaccine.2003.09.035","article-title":"Experimental infection by Chlamydia pneumoniae in the hamster","volume":"22","author":"Sambri","year":"2004","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06013211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06013211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T23:48:00Z","timestamp":1683676080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06013211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":54,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0264410X06013211"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.12.003","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}